The doctors shared graphic descriptions of objects removed from the eyes of patients. Those stories didn’t make it into the ...
We present one of the first comprehensive evaluations of predictive information derived from retinal fundus photographs, illustrating the potential and limitations of readily accessible and low-cost ...
Age-related macular degeneration (AMD) is the leading cause of blindness in the West. Delays in injections can cause ...
The FDA has, for a third time, declined to approve reproxalap for the treatment of dry eye disease, according to a press ...
In its complete response letter, the FDA said Aldeyra had failed to demonstrate reproxalap’s efficacy in adequate and ...
March 17 (Reuters) - The U.S. Food and Drug Administration declined to approve Aldeyra Therapeutics' drug for a type of eye ...
Women over 50 face increased eye health risks post-menopause due to hormonal shifts. Conditions like dry eye, cataracts, glaucoma, and age-related macular degeneration become more prevalent.
Scientists found that protein deposits in the retina create unique light patterns for different brain diseases in humans.
Prevent Blindness, the nation's leading patient advocacy organization dedicated to preventing blindness and preserving sight, has declared March 23-29, 2026, as its first-ever Keratoconus Week. The ...
This ophthalmic biopharma firm develops sustained drug delivery therapies for eye diseases, targeting both U.S. and global ...
With the singular exception of punctal or canalicular occlusion, when we are talking about in-office dry eye disease ...
After delaying its review, the FDA has rejected Aldeyra Therapeutics’ experimental dry eye disease treatment for the third time. | After delaying its review, the FDA has rejected Aldeyra Therapeutics’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results